First Page | Document Content | |
---|---|---|
Date: 2014-10-01 21:56:23Melanoma Organochlorides Organofluorides Sulfonamides Vemurafenib BRAF Ipilimumab Dacarbazine End point of clinical trials Medicine Chemistry Oncology | Microsoft WordDabrafenib GSK PSD March 13 final...docxAdd to Reading ListSource URL: www.pbs.gov.auDownload Document from Source WebsiteFile Size: 94,43 KBShare Document on Facebook |
Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar NoDocID: 1rqYi - View Document | |
Microsoft WordDOCXDocID: 1rnqZ - View Document | |
Beilage 1: ArzneimittelmonographienDocID: 1rinj - View Document | |
SAFETY DATA SHEET Page 1 of Total 6 Date of Issue: August 2016 SDS No. FMC/RAD/1 SECTION 1DocID: 1rdYu - View Document | |
imatinib and colon cancer. imatinib availability imatinib and cml imatinib and tight junction cancer imatinib prostate dercum and imatinib zactima plus imatinibDocID: 1rdbp - View Document |